These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11124624)

  • 1. Erythropoietin, oxidative metabolism and dialysis.
    Ionova D; Sepetlieva K; Tcachev K
    Nephron; 2000 Dec; 86(4):544. PubMed ID: 11124624
    [No Abstract]   [Full Text] [Related]  

  • 2. Oxidative stress in renal anemia of hemodialysis patients is mitigated by epoetin treatment.
    Siems W; Carluccio F; Radenkovic S; Grune T; Hampl H
    Kidney Blood Press Res; 2005; 28(5-6):295-301. PubMed ID: 16534224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant human erythropoietin and haemodialyser re-use.
    Dos Santos JP; Prata MM; Sousa FT; Barbas JV
    Nephron; 1990; 56(4):447-8. PubMed ID: 2080010
    [No Abstract]   [Full Text] [Related]  

  • 4. [Improvement of the quality of life for hemodialysis patients using recombinant human erythropoietin].
    Schaefer RM
    Krankenpfl J; 1988; 26(7-8):317-20. PubMed ID: 3419139
    [No Abstract]   [Full Text] [Related]  

  • 5. Erythropoietin.
    Haberl M
    Aust Nurses J; 1990 Sep; 20(2):29. PubMed ID: 2268202
    [No Abstract]   [Full Text] [Related]  

  • 6. [The importance of erythropoietin in the therapy of anemia in patients on chronic hemodialysis].
    von Appen K; Klinkmann H
    Urol Nefrol (Mosk); 1990; (6):69-70. PubMed ID: 2089771
    [No Abstract]   [Full Text] [Related]  

  • 7. [Erythropoietin, aluminum and renal anemia].
    Schaefer M; Heidland A
    Dtsch Med Wochenschr; 1990 Jun; 115(22):878-9. PubMed ID: 2347300
    [No Abstract]   [Full Text] [Related]  

  • 8. Management of the chronic renal failure patient receiving epoetin alfa for the treatment of anemia.
    Binkley LS
    Transplant Proc; 1991 Apr; 23(2):1831-2. PubMed ID: 2053169
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of human recombinant erythropoietin treatment on erythrocyte delta-aminolevulinic acid dehydratase in patients on maintenance hemodialysis.
    Djordjević VB; Pavlović D; Pejović M; Lecić N; Koraćević D; Djordjević V; Stefanović V
    Nephron; 1993; 65(3):497-8. PubMed ID: 8290015
    [No Abstract]   [Full Text] [Related]  

  • 10. Excessive level of parathyroid hormone may induce the reduction of recombinant human erythropoietin effect on renal anemia.
    Fujita Y; Inoue S; Horiguchi S; Kuki A
    Miner Electrolyte Metab; 1995; 21(1-3):50-4. PubMed ID: 7565462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Erythropoietin and dialyzed patients].
    Kreis H
    Rev Prat; 1989 Dec; 39(28):2530-1. PubMed ID: 2602881
    [No Abstract]   [Full Text] [Related]  

  • 12. Reduced glutathione for the treatment of anemia during hemodialysis: a preliminary communication.
    Zachée P; Ferrant A; Daelemans R; Goossens W; Boogaerts MA; Lins RL
    Nephron; 1995; 71(3):343-9. PubMed ID: 8569984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. When should we start erythropoietin therapy?
    O'Riordan E; Foley RN
    Nephrol Dial Transplant; 2001 May; 16(5):891-2. PubMed ID: 11328891
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of recombinant human erythropoietin on interleukin-1 beta and interleukin-6 in patients on maintenance hemodialysis.
    Sayinalp N; Erdem Y; Haznedaroğlu IC; Dündar S; Cağlar S; Kirazli S
    Clin Nephrol; 1995 Dec; 44(6):404. PubMed ID: 8719556
    [No Abstract]   [Full Text] [Related]  

  • 15. Desferrioxamine versus erythropoietin for treatment of dialysis anaemia.
    Padovese P; Gallieni M; Galmozzi C; Brancaccio D
    Lancet; 1990 Jun; 335(8703):1465. PubMed ID: 1972238
    [No Abstract]   [Full Text] [Related]  

  • 16. Haemoglobin concentrations in chronic kidney disease.
    Steinbrook R
    Lancet; 2006 Dec; 368(9554):2191-3. PubMed ID: 17189015
    [No Abstract]   [Full Text] [Related]  

  • 17. [Erythropoietin, blood viscosity and hypertension in chronic kidney failure].
    Schaefer RM; Heidland A
    Dtsch Med Wochenschr; 1989 Jun; 114(26):1046-9. PubMed ID: 2661190
    [No Abstract]   [Full Text] [Related]  

  • 18. A randomized double-blind study of recombinant human erythropoietin in anaemic hemodialysis patients. Canadian Erythropoietin Study Group.
    Laupacis A
    Transplant Proc; 1991 Apr; 23(2):1825-6. PubMed ID: 2053167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible relation between restless legs and anaemia in renal dialysis patients.
    Roger SD; Harris DC; Stewart JH
    Lancet; 1991 Jun; 337(8756):1551. PubMed ID: 1675404
    [No Abstract]   [Full Text] [Related]  

  • 20. The use of human recombinant erythropoietin in children on chronic dialysis.
    Sallay P; Reusz G
    Acta Paediatr Hung; 1992; 32(4):333-45. PubMed ID: 1304191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.